Family offices building up infra and healthtech assets
Economic developments in Asia present investment opportunities and current high valuations may be "an accident waiting to happen", say investors.
Tag : healthcare
Sovereign funds seek diamonds in the Covid rough
Healthcare and technology start-ups remain hot property, but pandemic-fuelled uncertainty has led to lower valuations in some areas, such as travel-related platforms.
Why instos are getting keen on Chinese healthcare PE
More asset owners are looking to support healthcare private equity funds amid the pandemic. But aspiring funds also face rising competition, increasing asset costs and geopolitical risk.
Sovereign funds’ Covid-19 challenges and opportunities
State wealth funds look set to invest more at home thanks to the pandemic, but their increased allocations to healthcare and tech should prove beneficial, says a new report.
JP Morgan Private Bank hunts for niche tech plays
The firm's investment head for Asia says it's hard to find pure-play products for robotics and and cyber-security, which are both increasingly popular themes among clients.
GPs play arbitrage amid soaring China valuations
Private equity firms in Greater China are exploiting the valuation differentials between China and markets such as the US, as well as between private and public markets.
.jpg&h=320&w=480&q=100&v=20190520&c=1)
